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As I often said, human beings were
made to carry one baby at a time.
Twin gestations, although seemingly
exiting for both mothers and provi-
ders, are indeed associated with much
higher complications for both mothers
and babies. The most frequent and
deadly of these complications is pre-
term birth (PTB). So the quest to
decrease PTB in twins is an extremely
important one. The best preventive
measure for now is surely reducing the
incidence of twins in the first place,
through the better use of assisted
reproductive techniques. This is
because once a woman is carrying
twins, nothing seems to work. The
contribution from Jarde et al. to this
issue of BJOG confirms this truth.
Though a systematic review and meta-
analysis of the literature, they showed
that neither pessary, nor cerclage, nor
vaginal progesterone prevented PTB in
twins with a short transvaginal ultra-
sound (TVU) cervical length (CL). A
few things should be highlighted.
First, most of the 23 randomised con-
trolled trials (RCTs) in the meta-analy-
sis included mostly ‘unselected’ twins. It
appears to be true that unselected twin
gestations do not benefit from vaginal
progesterone, pessary, or cerclage. Any
possible benefit came in subgroups with
short TVU CL. Just ‘throwing’ an inter-
vention at all twins with the hope of
preventing PTB does not seem to work,
and such RCTs should probably not be
prioritised anymore.
Second, twins with prior PTB have not
been studied separately and sufficiently
for these three interventions of proges-
terone, cerclage, and pessary.
Third, the addition of short TVU CL
to the risk factor of twins seemed to be
helpful in identifying a subgroup of
twins who could benefit from interven-
tion. Unfortunately, TVU CL in twins
only has ~40% sensitivity for PTB
(Conde-Agudelo et al. Am J Obstet
Gynecol 2010; 203:128.e1–12.). That is,
60% of twins have PTB without show-
ing a short CL in the second-trimester
screening. In contrast, TVU CL has a
70% sensitivity for PTB in singletons
with both a prior PTB and a short
TVU CL, and it’s not surprising that in
this population cerclage has been
shown to be associated with a reduc-
tion in PTB (Berghella et al. Obstet
Gynecol. 2011;117:663–71).
Fourth, in twins with a short
TVU CL, vaginal progesterone seems to
be for now the most promising inter-
vention. Although Jarde et al. empha-
sise the possible benefit in secondary
outcomes of this intervention in all
twins, on a close reading of each related
RCT the benefit of vaginal progesterone
seems to come just in twins with a short
TVU CL. These data confirm two prior
meta-analyses on vaginal progesterone
alone in twins with short CL (Schuit et
al. BJOG 2015;122:27–37, Romero et al.
Am J Obstet Gynecol 2012;206:124.e1–19).
Most of the women included had a TVU
CL of ≤25 mm.
Fifth, in twins with short TVU CL, a
pessary has been reported to be beneficial
in two RCTs (Liem et al Lancet
2013;382:1341–9 and Goya et al Am J
Obstet Gynecol. 2016 Feb;214(2):145–52)
and not beneficial in two other RCTs
(Nicolaides et al Am J Obstet Gynecol.
2016;214:3.e1–9 and Berghella et al.
Ultrasound Obstet Gynecol, 2017; doi:
10.1002/uog.17430); therefore, it remains
unclear whether a pessary is beneficial in
this population.
Finally, only 49 sets of twins with
short CL have been included in RCTs of
cerclage versus no cerclage (Saccone Acta
Obstet Gynecol Scand 2015;94:352–8).
Clearly more RCTs are needed to answer
this question.
For now, we at our institution are
continuing to perform RCTs in twins
with a short TVU CL: we just finished
a study on pessary [Berghella et al.
AJOG 2017 (in press)], and are starting
another on cerclage. Surely the comple-
tion and publication of the continuing
RCTs on interventions for twins with a
short TVU CL (Table S1) will soon
revolutionise the management of twins.
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